Nanogen, Silicon Genetics, Gene Logic, Affymetrix, DNAPrint | GenomeWeb

Nanogen has released a multiplex analyte specific reagent for the detection of Factor V Leiden and Factor II prothrombin gene mutations. The company said CLIA-certified laboratories can use the reagents to create and validate tests that detect these mutations.

The ASR for Factor V/Factor II prothrombin covers mutations tied to cardiovascular disease and thrombosis, respectively, and comprises reagents, controls, and analysis of the G1691A mutation on the Factor V gene and the G20210A mutation on the prothrombin gene, according to Nanogen.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.